AXSOME THERAPEUTICS, INC. (AXSM) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
AXSOME THERAPEUTICS, INC. (AXSM) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$460.45 MLiabilities$678.14 MCurrent assets$656.57 MNon-current liabilities$217.70 MAssets$761.45 MEquity$83.30 MGross equity(calculated)$1.51 BNon-current assets$104.88 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsAccounts receivable, netInventories, netPrepaid and other current assetsIntangible asset, netNon-current inventory and other assetsRight-of-use asset - operating leaseGoodwillEquipment, netAccrued expenses and other current liabilitiesAccounts payableShort-term borrowingsContingent consideration, currentOperating lease liability, current portionLoan payable, long-termContingent consideration, non-currentOperating lease liability, long-termFinance lease liability, long-termAdditional paid-in capitalCommon stock, $0.0001 par value per share (150,000,000 shares authorized, 52,299,889 and 50,882,766 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively)Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitCurrent liabilitiesCurrent liabilities$460.45 MAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$299.63 MLiabilitiesLiabilities$678.14 MAccounts payableAccounts payable$78.97 MShort-term borrowingsShort-term borrowings$70.00 MContingent consideration, currentContingent consideration, current$11.20 MOperating lease liability, current portionOperating lease liability, current portion$646.00 KCurrent assetsCurrent assets$656.57 MNon-current liabilitiesNon-current liabilities$217.70 MLoan payable, long-termLoan payable, long-term$117.96 MCash and cash equivalentsCash and cash equivalents$319.85 MContingent consideration, non-currentContingent consideration, non-current$69.14 MAssetsAssets$761.45 MEquityEquity$83.30 MOperating lease liability, long-termOperating lease liability, long-term$21.57 MFinance lease liability, long-termFinance lease liability, long-term$9.03 MGross equity (calculated)Gross equity(calculated)$1.51 BAccounts receivable, netAccounts receivable, net$277.46 MInventories, netInventories, net$37.88 MPrepaid and other current assetsPrepaid and other current assets$21.38 MIntangible asset, netIntangible asset, net$37.36 MNon-current assetsNon-current assets$104.88 MNon-current inventory and other assetsNon-current inventory and other assets$35.45 MRight-of-use asset - operating leaseRight-of-use asset - operating lease$19.16 MGoodwillGoodwill$12.04 MAdditional paid-in capitalAdditional paid-in capital$1.51 BEquipment, netEquipment, net$874.00 KCommon stock, $0.0001 par value per share (150,000,000 shares authorized, 52,299,889 and 50,882,766 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively)Common stock$5.00 KAccumulated deficitAccumulated deficit−$1.42 B
Chart details

AXSOME THERAPEUTICS, INC. (AXSM) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
761,447,000 US dollars
Current assets
656,569,000 US dollars
Non-current assets
104,878,000 US dollars
Liabilities
678,143,000 US dollars
Current liabilities
460,446,000 US dollars
Non-current liabilities
217,697,000 US dollars
Equity
83,304,000 US dollars
Cash and cash equivalents
319,850,000 US dollars
Accounts receivable, net
277,459,000 US dollars
Inventories, net
37,883,000 US dollars
Prepaid and other current assets
21,377,000 US dollars
Intangible asset, net
37,358,000 US dollars
Non-current inventory and other assets
35,447,000 US dollars
Right-of-use asset - operating lease
19,157,000 US dollars
Goodwill
12,042,000 US dollars
Equipment, net
874,000 US dollars
Accrued expenses and other current liabilities
299,632,000 US dollars
Accounts payable
78,969,000 US dollars
Short-term borrowings
70,000,000 US dollars
Contingent consideration, current
11,199,000 US dollars
Operating lease liability, current portion
646,000 US dollars
Loan payable, long-term
117,958,000 US dollars
Contingent consideration, non-current
69,135,000 US dollars
Operating lease liability, long-term
21,574,000 US dollars
Finance lease liability, long-term
9,030,000 US dollars
Additional paid-in capital
1,505,116,000 US dollars
Common stock, $0.0001 par value per share (150,000,000 shares authorized, 52,299,889 and 50,882,766 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively)
5,000 US dollars
Accumulated deficit
negative 1,421,817,000 US dollars
Gross equity (calculated)
1,505,121,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
AXSOME THERAPEUTICS, INC. (AXSM) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!